Last reviewed · How we verify
Generalized myasthenia gravis
Approved treatments
- RYSTIGGO · UCB INC
- Ultomiris · AstraZeneca
Ultomiris blocks the action of Complement C5 to prevent inflammation and damage to red blood cells. - ULTOMIRIS · ALEXION PHARM
- Ultomiris · Alexion Pharmaceuticals, Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Generalized myasthenia gravis patent landscape — cliff calendar, originator estates, attackable patents
- Generalized myasthenia gravis treatment landscape brief
- Generalized myasthenia gravis treatment updates RSS
Frequently asked questions about Generalized myasthenia gravis
What drugs treat Generalized myasthenia gravis?
Tracked treatments include RYSTIGGO, Ultomiris, ULTOMIRIS.
What is the treatment for Generalized myasthenia gravis?
Standard treatment for Generalized myasthenia gravis includes RYSTIGGO, Ultomiris, ULTOMIRIS. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Generalized myasthenia gravis patent cliff · Generalized myasthenia gravis CI report
- Treatment: RYSTIGGO · UCB INC
- Treatment: Ultomiris · AstraZeneca
- Treatment: ULTOMIRIS · ALEXION PHARM
- Treatment: Ultomiris · Alexion Pharmaceuticals, Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing